• English
  • Eesti

The Estonian medicinal products market in fourth quarter 2017

Printer-friendly version

Estonian drug statistics is based on wholesalers’ reports. The statistics of human medicinal products includes sales to general and hospital pharmacies and to other institutions, i.e. state and scientific institutions. The statistics of veterinary medicinal products includes sales to general and veterinary pharmacies, veterinarians and to other institutions. The medicinal products market is expressed in wholesale prices which includes the price of the manufacturer and wholesaler’s mark-up and does not include the VAT.

Human medicines

In the fourth quarter of 2017 the medicinal products market increased 8.1 % reaching to 80.3 million euros. Estonian human medicines market of previous five years shows also an increasing trend:

Sales to general pharmacies were 55.4 million euros, sales to hospital pharmacies 24.3 million euros and sales to other institutions 0.6 million euros.

Prescription sales covered most of the medicinal products market, being 68.2 million euros. The turnovers of over the counter sales and hospital package sales were 11.6 million euros and 0.5 million euros.

Based on ATC classification, the most sold medicines by turnover, were antineoplastic and immunomodulating agents (15.8 million euros), antiinfectives for systemic use (12.6 million euros) and alimentary tract and metabolism medicines (9.5 million euros).

Defined Daily Dose (DDD) is the assumed average dose per day for the drug used in its main indication in adults. Defined Daily Dose per thousand inhabitants a day (DDD/1000/day) expresses the proportion of the population within a defined area treated daily with certain drugs.

According to DDD/1000/day the most consumed medicines in the fourth quarter of 2017 were cardiovascular system drugs (431 DDD/1000/day), alimentary tract and metabolism drugs (179 DDD/1000/day) and nervous system medicines (132 DDD/1000/day).

The most consumed active substances were:

ATC group / INN (rout of admin.)




Acetylsalicylic acid +Magnesium oxide



















In the fourth quarter of 2017, 3700 different medicinal preparation packages and 1200 active substances were marketed in Estonia.

Veterinary medicines

The Estonian veterinary medicinal products market was 3.24 million euros in wholesale prices in the fourth quarter of 2017. Compared to the same period in 2016 the turnover increased 18.7%. The main reason was the significant increase in turnover of immunologicals, 47.7% compared to the same period of the previous year.

The most sold medicines by turnover were antiinfectives for systemic use, immunologicals, antiparasitic products, alimentary tract and metabolism and musculo-sceletal products.

Almost 85% of veterinary medicines were sold to the veterinarians or to the agricultural companies represented by a veterinarian, 2.5% to the general pharmacies, 6.5% to the veterinary pharmacies and 6% to other institutions (generally state- and scientific institutions).